“likely,”“projects,”“predicts,”“continue,”“will,”“schedule,” and “would” or, in each case, their negative or other variations or comparable terminology, are intended to identify forward-looking...
The subcommittee determined that patient eligibility, preference of schedule, experience of the treating physician, and drug availability/insurance coverage should be considered when choosing among atezolizumab, nivolumab, and pembrolizumab. PD-L1 Testing Herbst acknowledged that PD-L1 is the best biomarker...
The words "believes," "anticipates," "estimates," "plans," "expects," "intends," "may," "could," "should," "potential," "likely," "projects," “predicts,” "continue," "will," “schedule,” and "would" or, in each case, their negative or other variations...
has shown durable antitumor activities with manageable safety profile in an outpatient setting. In order to make nemvaleukin treatment administration more convenient for both patients and providers, we initiated the ARTISTRY-3 clinical trial to evaluate the effects of a less frequent I...
Data were presented on 159 patients receiving combination therapy with vidutolimod and pembrolizumab. Two formulations of vidutolimod were evaluated, either polysorbate 20 at 0.01% (PS20, n=98) or x PS20 at 0....